|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest bearing deposits in other banks | ||||||||||||||||||||
| Securities available for sale | ||||||||||||||||||||
| Securities to be held to maturity (fair value of $339,011,000 at December 31, 2022, and $375,327,000 at December 31, 2021) | ||||||||||||||||||||
| Securities held-to-maturity (net of ACL), fair value of $311,221,000 at June 30, 2026, $315,482,000 at December 31, 2025 and $312,508,000 at June 30, 2025 | ||||||||||||||||||||
| Restricted equity securities, at cost | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Less allowance for credit losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Demand deposits | ||||||||||||||||||||
| NOW deposits | ||||||||||||||||||||
| Money market deposits | ||||||||||||||||||||
| Savings deposits | ||||||||||||||||||||
| Certificates of deposit | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowed funds – short term | ||||||||||||||||||||
| Borrowed funds – long term | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| Common stock, one cent par value per share | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Net unrealized loss on securities available-for-sale | ||||||||||||||||||||
| Net unrealized loss on securities transferred from available-for-sale to held-to-maturity | ||||||||||||||||||||
| Net unrealized gain on cash flow hedging derivative instruments | ||||||||||||||||||||
| Net unrealized gain on postretirement costs | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities & shareholders' equity | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Number of shares authorized (in shares) | ||||||||||||||||||||
| Number of shares issued (in shares) | ||||||||||||||||||||
| Number of shares outstanding (in shares) | ||||||||||||||||||||
| Book value per common share (usd per share) | ||||||||||||||||||||
| Tangible book value per common share (usd per share) | ||||||||||||||||||||
Loading...
